| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $200K | +80.9% | +53.6% |
| R&D Expense | $724K | — | +550.8% |
| SG&A Expense | $16.6M | +902.5% | +5460.2% |
| Operating Income | -$20.1M | -1004.0% | -4490.9% |
| Interest Expense | $100K | — | +0.0% |
| Pre-tax Income | -$20.4M | -1037.1% | — |
| Net Income | -$20.4M | -1036.9% | — |
| EPS (Basic) | -$0.60 | +45.9% | -5900.0% |
| EPS (Diluted) | -$0.60 | +45.9% | -5900.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $33K | -0.7% | -76.6% |
| Current Assets | $2.4M | -68.4% | -23.1% |
| Total Assets | $28.8M | +230.8% | +182.8% |
| Current Liabilities | $6.3M | +2521.6% | +2067.2% |
| Total Liabilities | $12.5M | +4016.7% | +3340.0% |
| Stockholders' Equity | $16.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.6M | — | — |
| Investing Cash Flow | -$1.8M | — | — |
| Financing Cash Flow | $7.4M | — | — |
| +65.8% |